Recent breakthrough in our understanding pertaining to the pathogenesis of nonalcoholic
fatty liver disease (NAFLD) has pointed to dysregulation or derangement of the gut …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic consequence of metabolic
syndrome, which often also includes obesity, diabetes, and dyslipidemia. The connection …

In recent years, close links between intestinal microbiota and host metabolism have been
recognized. Intestinal bacteria can participate in the extraction of calories from food, and …

Background Non‐alcoholic fatty liver disease (NAFLD) has become the most common
chronic liver condition. A major current research effort is ongoing to find potential strategies …

Abstract Background and Aim Patients with non‐alcoholic fatty liver disease (NAFLD) exhibit
compositional changes in their gut microbiome, which represents a potential therapeutic …

Alterations in the gut–liver axis and changes in the gut microbiome are among the risk
factors for the pathogenesis of non-alcoholic fatty liver disease (NAFLD). These patients …

Nonalcoholic fatty liver disease (NAFLD) is currently recognized as one of the most common
causes of chronic liver disease. It involves a spectrum of conditions that include pure …

Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature
reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently …

Modifications in the microbiota caused by environmental and genetic reasons can
unbalance the intestinal homeostasis, deregulating the host's metabolism and immune …

Nonalcoholic fatty liver disease (NAFLD) is leading chronic liver syndrome worldwide. Gut
microbiota dysbiosis significantly contributes to the pathogenesis and severity of NAFLD …